Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
105.44
+1.53 (1.47%)
At close: Jul 3, 2025, 1:00 PM
105.00
-0.44 (-0.42%)
After-hours: Jul 3, 2025, 4:42 PM EDT
Axsome Therapeutics Employees
Axsome Therapeutics had 683 employees as of December 31, 2024. The number of employees increased by 138 or 25.32% compared to the previous year.
Employees
683
Change (1Y)
138
Growth (1Y)
25.32%
Revenue / Employee
$632,734
Profits / Employee
-$407,426
Market Cap
5.21B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AXSM News
- 16 days ago - Axsome Therapeutics Champions Brain Health During Alzheimer's & Brain Awareness Month - GlobeNewsWire
- 25 days ago - Axsome Therapeutics Showcases Innovation in Sleep Medicine with Multiple Presentations for AXS-12 and Solriamfetol at SLEEP 2025 - GlobeNewsWire
- 5 weeks ago - Axsome Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Axsome Therapeutics Settles SUNOSI® (solriamfetol) Patent Litigation with Hetero Labs Ltd. - GlobeNewsWire
- 7 weeks ago - Axsome Therapeutics Enters $570 Million Term Loan and Revolving Credit Facility with Blackstone - GlobeNewsWire
- 2 months ago - Axsome Therapeutics Q1: Marketing-Driven Growth Masks Profitability Concerns - Seeking Alpha
- 2 months ago - Axsome Therapeutics, Inc. (AXSM) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Axsome Therapeutics Clocks Around 60% Topline Growth In Q1 - Benzinga